CervAIcal vs GYNStat

CervAIcal is more than just an app; it's a revolution in healthcare, dedicated to the early detection and prevention of cervical cancer. As the fourth most prevalent cancer in women worldwide, cervical cancer poses a significant risk, particularly for women over the age of 30. In 2018 alone, an estimated 570,000 women were diagnosed, and approximately 311,000 lives were lost to this disease. But with CervAIcal, we aim to change this narrative. Key Features: Innovative Screening Tool: Utilizing advanced AI technology, cervAIcal offers a user-friendly platform for initial cervical cancer screening. This tool is designed to analyze symptoms and risk factors, providing a preliminary assessment that guides users on whether a consultation with a healthcare professional is recommended. Privacy and Security: Your health data is sensitive, and we treat it with the utmost confidentiality. cervAIcal uses robust encryption methods to secure your personal information. Disclaimer: Please seek doctor’s advice in addition to using this app and before making any medical decisions.

GYNStat is a clinical decision support tool built for obstetricians and gynecologists. Designed for use at the bedside, in clinic, and on call, GYNStat brings together the calculators, staging systems, scoring tools, and guideline references that OB/GYN clinicians reach for every day — in one fast, private, offline-capable app. Whether you are evaluating an adnexal mass, staging a cervical cancer, screening for preeclampsia, or working up an abnormal Pap, GYNStat gives you a structured, evidence-based answer in seconds. Modules • 40+ clinical calculators across obstetrics, gynecologic oncology, reproductive endocrinology, infectious disease, and emergency care • FIGO staging for cervical, endometrial, ovarian, vulvar, and gestational trophoblastic disease • IOTA Simple Rules and ADNEX model for adnexal mass risk stratification • ROMA score for ovarian malignancy risk • WHO Medical Eligibility Criteria for contraception • Preeclampsia screening and severe features assessment • Gestational diabetes (GDM) screening and diagnosis • PCOS Rotterdam criteria and HOMA-IR insulin resistance • Emergency: postpartum hemorrhage, eclampsia, ectopic, sepsis • Bleeding: PALM-COEIN, AUB workup • Infection: BV (Amsel and Nugent), trichomoniasis, PID • Screening: cervical cytology management, mammography intervals • Pregnancy dating, EDD, growth percentiles, Bishop score • POP-Q pelvic organ prolapse staging • Endometrial biopsy interpretation Guidelines Direct access to current recommendations from FIGO, ACOG, WHO, ESHRE, RCOG, NICE, CDC, and ASRM. Every clinical module includes a References & Guidelines card linking the calculator output to the source recommendation. Privacy • All patient data stays on your device — nothing is uploaded • No ads, no third-party tracking, no analytics SDKs • Apple privacy-compliant; works fully offline • Designed for HIPAA-aware clinical workflows Disclaimer GYNStat is a decision support tool for licensed clinicians. It does not replace clinical diagnosis, examination, or treatment. Final clinical judgment always rests with the treating physician. Always confirm dosing, staging criteria, and management against your local protocols and the latest published guidelines.